Welcome to our dedicated page for United States Antimony SEC filings (Ticker: UAMY), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
United States Antimony Corporation filings document the public-company record for an antimony, zeolite and critical-minerals producer and processor. Recent 8-K reports cover operating and financial results, conference-call materials, officer and finance-leadership changes, and operational updates tied to the Fostung tungsten property and its Technical Report Summary.
The company’s proxy materials describe annual-meeting voting matters and shareholder governance procedures. Its Form 25 records the withdrawal of common stock from NYSE American following the completed transfer of the listing to the New York Stock Exchange, while later current reports identify UAMY common stock as listed on the NYSE and NYSE Texas. The filings also disclose the company’s common stock class, par value, reporting status, and material-event exhibits.
United States Antimony Corporation entered into a five-year supply agreement with a large U.S. industrial fabric manufacturer for antimony trioxide, a key ingredient in flame‑retardant materials. The agreement was executed on November 7, 2025 and reflects a multi‑year commercial commitment for product sales.
The company announced the deal via press release on November 11, 2025. The purchasing and supply agreement is filed as Exhibit 10.1, with a press release attached as Exhibit 99.1.
United States Antimony Corporation (UAMY): Patrick Dugan and the Estate of Lydia Dugan filed Amendment No. 4 to Schedule 13D, an exit filing, after selling shares and reducing their beneficial ownership below 5%.
The group reports beneficial ownership of 5,700,560 shares, representing 4.1% of the class, based on 138,878,411 shares outstanding as of October 13, 2025. Dispositions disclosed include 1,022,089 shares at $9.41 per share (transaction effected on October 28, 2025) and 1,346,278 shares at $9.29 per share (transaction effected on October 29, 2025). The filing states they ceased to be beneficial owners of more than five percent of the issuer’s securities.
United States Antimony Corporation announced the schedule for releasing its Third Quarter and Nine Months Ended September 30, 2025 financial and operating results. The company will host a conference call and webcast on November 12, 2025 at 4:15 p.m. Eastern time.
Access details are provided in a press release attached as Exhibit 99.1. The information was furnished under Item 8.01 and is not deemed filed under Section 18 of the Exchange Act.
United States Antimony Corporation filed a Form 8-K stating it issued a press release on October 30, 2025 with an operational update and a preliminary update to Fiscal 2026 revenue guidance. The press release is included as Exhibit 99.1.
The company furnished this information under Item 7.01 (Regulation FD Disclosure), which means it is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not incorporated by reference unless specifically noted.
United States Antimony Corporation (UAMY) filed an 8‑K announcing a non‑binding, indicative proposal to acquire Larvotto Resources Limited. On October 17, 2025, USAC submitted terms offering six (6) USAC shares for every one hundred (100) Larvotto shares. The company also disclosed it has recently acquired approximately 10% of Larvotto’s ordinary shares.
The proposal is subject to negotiation and execution of a binding scheme implementation deed, Larvotto shareholder approval, regulatory approvals, and customary closing conditions. USAC furnished a related press release under Regulation FD. The disclosure outlines the proposed share‑for‑share ratio and approvals required, indicating an early, non‑binding stage in a potential combination.
United States Antimony Corporation filed a prospectus supplement for an at‑the‑market program to offer and sell up to $400,000,000 of common stock under its automatic shelf registration on Form S‑3. Sales may be made through A.G.P./Alliance Global Partners and B. Riley Securities pursuant to an amended and restated sales agreement.
Offerings will be made only by means of the prospectus supplement and the base prospectus. A legal opinion from Duane Morris LLP regarding the validity of the shares was filed as Exhibit 5.1.
United States Antimony Corporation commenced an at-the-market offering of up to $400,000,000 of common stock, to be sold from time to time through A.G.P./Alliance Global Partners and B. Riley Securities as agents or principals. Sales may be made pursuant to Rule 415(a)(4) with no minimum amount required.
The company will pay the Agents up to 3.0% of the gross sales price per share and plans to use any net proceeds to acquire antimony and other critical mineral inventory, expand leasehold positions in Alaska and Montana, pursue acquisitions, potentially increase capacity at the Madero Smelter in Mexico, and for general working capital.
As context, the last reported sale price was $16.71 per share on October 13, 2025, and shares outstanding were 138,878,411 as of that date. The filing illustrates potential dilution: at an assumed price of $16.71, pro forma as adjusted net tangible book value would be $3.24 per share, implying $13.47 per-share dilution to new investors.
United States Antimony Corporation entered a Securities Purchase Agreement for a registered direct offering of 2,377,657 shares of common stock at $10.50 per share, for approximately $25 million in gross proceeds. The company expects net proceeds of $24,431,090.53 after the placement commission and a credit, with closing expected on or about October 14, 2025, subject to customary conditions.
The deal is being made off the company’s effective Form S-3 shelf and a Rule 462(b) S-3MEF. Titan Partners Group acted as exclusive placement agent with a 7% commission, subject to a credit. Separately, the company reduced its ATM capacity from $65,000,000 to $39,885,000 effective October 6, 2025, and as of October 10, 2025, cannot sell under the existing ATM prospectus supplement unless and until new offering documents are filed; the sales agreement remains in force.
United States Antimony Corporation is conducting a primary offering of 2,377,657 shares of common stock at $10.50 per share, for gross proceeds of $24,965,398.50. Titan Partners Group LLC is acting as exclusive placement agent on a best-efforts basis and will receive a 7.0% cash fee, with net proceeds to the company, after fees, reimbursable expenses and a closing credit, stated as $24,431,090.53.
Shares outstanding are expected to increase to 138,878,411 from 136,500,754 as of October 9, 2025. The company plans to use the funds to buy additional antimony and other critical mineral inventories, expand leasehold positions in Alaska and Montana, pursue acquisitions of critical mineral businesses or properties, potentially increase capacity at its Madero smelter in Mexico, and for general working capital. The company highlights that new investors will face immediate dilution, with pro forma net tangible book value moving to $1.00 per share versus the $10.50 offering price.
John M. Keane, a director of United States Antimony Corp (UAMY), filed an Initial Statement of Beneficial Ownership reporting no currently owned common shares and two time‑based awards granted on 08/19/2025. The filing shows 68,200 restricted stock units (RSUs) and a stock option covering 34,100 shares, each vesting one‑third on 08/19/2026, 08/19/2027, and 08/19/2028$4.26 and an expiration date of 08/19/2035. The RSUs convert to common stock at vesting; no direct common shares were reported.